Five clusters that map to how medtech teams actually divide work. Each one bundles the roadmap stages, glossary terms, investor lists and live feeds you need - no hunting.
Cleared, compliant, audit-ready.
FDA pathways (510(k), De Novo, PMA), design controls, ISO 13485 / QMSR, and the paperwork that decides whether your device ships.
From bench to billable.
Pre-clinical, pivotal trials, CPT codes, coverage decisions and the payer dossier - the difference between cleared and paid for.
Capital that actually closes.
Active medtech VCs, corporate strategics, accelerators and non-dilutive grants (SBIR/STTR, BARDA, ARPA-H). Plus the live funding tape.
524B, SBOM, threat model - done right.
FDA premarket cyber (524B), post-market vulnerability management, SBOM hygiene, and CISA advisories you need to act on.
Win KOLs, IDNs and the second sale.
Pricing, channel, hospital contracting, KOL strategy and the post-market signals that decide whether you re-order.
We add clusters as readers request them. Manufacturing, post-market surveillance, M&A readiness - open queue.